BiVACOR
PrivateLast Round
Grant
Feb 20, 2024
Total Funding Raised
$39.58M
Company Overview
BiVACOR is a medical device company developing a total artificial heart to provide a long-term solution for patients with end-stage biventricular heart failure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BiVACOR Comparables
Compare BiVACOR with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Carmat | 85% | |
| Picard Medical, Inc. | 83% | |
| Neocor Therapeutics | 82% | |
BiVACOR Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 20, 2024 | ||||
| VC Round | Mar 29, 2023 | ||||
| Series B | May 19, 2021 | ||||
| Grant | May 19, 2021 | ||||
| Series A | May 17, 2018 | ||||
Grant | Oct 25, 2017 |
BiVACOR Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OneVentures | Series B, Series A, VC Round |
| NIH RADx | Grant |
| Queensland Government | Grant |
| Monash University | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| Cormorant Asset Management | Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 7, 2025
Grew 16% QoQ, from 45 to 52 employees.
- Feb 20, 2024
Secured $13M from Medical Research Future Fund and Monash University.
BiVACOR Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BiVACOR's valuation, stock price, and market status.